img

Global Aprepitant Injection Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Aprepitant Injection Market Research Report 2024

Arepidan injection is a submicron emulsion prepared by wrapping Arepidan in soybean oil. Compared with oral preparation, it can significantly improve the bioavailability and drug compliance; At the same time, it can effectively reduce the incidence of anaphylaxis in the clinical use of similar injection preparations. It is a prescription drug for the treatment of nausea and vomiting caused by chemotherapy. It can be used alone or together with other drugs.
According to Mr Accuracy reports’s new survey, global Aprepitant Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Aprepitant Injection market research.
Key manufacturers engaged in the Aprepitant Injection industry include Heron Therapeutics, Inc. and Qilu Pharmaceutical etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Aprepitant Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Aprepitant Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Aprepitant Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Heron Therapeutics, Inc.
Qilu Pharmaceutical
Segment by Type
Injection
Injection Lotion

Segment by Application


Cancer Treatment Center
Hospital

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Aprepitant Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Aprepitant Injection Market Overview
1.1 Product Overview and Scope of Aprepitant Injection
1.2 Aprepitant Injection Segment by Type
1.2.1 Global Aprepitant Injection Market Value Comparison by Type (2024-2034)
1.2.2 Injection
1.2.3 Injection Lotion
1.3 Aprepitant Injection Segment by Application
1.3.1 Global Aprepitant Injection Market Value by Application: (2024-2034)
1.3.2 Cancer Treatment Center
1.3.3 Hospital
1.4 Global Aprepitant Injection Market Size Estimates and Forecasts
1.4.1 Global Aprepitant Injection Revenue 2018-2029
1.4.2 Global Aprepitant Injection Sales 2018-2029
1.4.3 Global Aprepitant Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Aprepitant Injection Market Competition by Manufacturers
2.1 Global Aprepitant Injection Sales Market Share by Manufacturers (2018-2024)
2.2 Global Aprepitant Injection Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Aprepitant Injection Average Price by Manufacturers (2018-2024)
2.4 Global Aprepitant Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Aprepitant Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aprepitant Injection, Product Type & Application
2.7 Aprepitant Injection Market Competitive Situation and Trends
2.7.1 Aprepitant Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aprepitant Injection Players Market Share by Revenue
2.7.3 Global Aprepitant Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aprepitant Injection Retrospective Market Scenario by Region
3.1 Global Aprepitant Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Aprepitant Injection Global Aprepitant Injection Sales by Region: 2018-2029
3.2.1 Global Aprepitant Injection Sales by Region: 2018-2024
3.2.2 Global Aprepitant Injection Sales by Region: 2024-2029
3.3 Global Aprepitant Injection Global Aprepitant Injection Revenue by Region: 2018-2029
3.3.1 Global Aprepitant Injection Revenue by Region: 2018-2024
3.3.2 Global Aprepitant Injection Revenue by Region: 2024-2029
3.4 North America Aprepitant Injection Market Facts & Figures by Country
3.4.1 North America Aprepitant Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Aprepitant Injection Sales by Country (2018-2029)
3.4.3 North America Aprepitant Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aprepitant Injection Market Facts & Figures by Country
3.5.1 Europe Aprepitant Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Aprepitant Injection Sales by Country (2018-2029)
3.5.3 Europe Aprepitant Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aprepitant Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Aprepitant Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Aprepitant Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Aprepitant Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Aprepitant Injection Market Facts & Figures by Country
3.7.1 Latin America Aprepitant Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Aprepitant Injection Sales by Country (2018-2029)
3.7.3 Latin America Aprepitant Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aprepitant Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Aprepitant Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Aprepitant Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Aprepitant Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aprepitant Injection Sales by Type (2018-2029)
4.1.1 Global Aprepitant Injection Sales by Type (2018-2024)
4.1.2 Global Aprepitant Injection Sales by Type (2024-2029)
4.1.3 Global Aprepitant Injection Sales Market Share by Type (2018-2029)
4.2 Global Aprepitant Injection Revenue by Type (2018-2029)
4.2.1 Global Aprepitant Injection Revenue by Type (2018-2024)
4.2.2 Global Aprepitant Injection Revenue by Type (2024-2029)
4.2.3 Global Aprepitant Injection Revenue Market Share by Type (2018-2029)
4.3 Global Aprepitant Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Aprepitant Injection Sales by Application (2018-2029)
5.1.1 Global Aprepitant Injection Sales by Application (2018-2024)
5.1.2 Global Aprepitant Injection Sales by Application (2024-2029)
5.1.3 Global Aprepitant Injection Sales Market Share by Application (2018-2029)
5.2 Global Aprepitant Injection Revenue by Application (2018-2029)
5.2.1 Global Aprepitant Injection Revenue by Application (2018-2024)
5.2.2 Global Aprepitant Injection Revenue by Application (2024-2029)
5.2.3 Global Aprepitant Injection Revenue Market Share by Application (2018-2029)
5.3 Global Aprepitant Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Heron Therapeutics, Inc.
6.1.1 Heron Therapeutics, Inc. Corporation Information
6.1.2 Heron Therapeutics, Inc. Description and Business Overview
6.1.3 Heron Therapeutics, Inc. Aprepitant Injection Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Heron Therapeutics, Inc. Aprepitant Injection Product Portfolio
6.1.5 Heron Therapeutics, Inc. Recent Developments/Updates
6.2 Qilu Pharmaceutical
6.2.1 Qilu Pharmaceutical Corporation Information
6.2.2 Qilu Pharmaceutical Description and Business Overview
6.2.3 Qilu Pharmaceutical Aprepitant Injection Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Qilu Pharmaceutical Aprepitant Injection Product Portfolio
6.2.5 Qilu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aprepitant Injection Industry Chain Analysis
7.2 Aprepitant Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aprepitant Injection Production Mode & Process
7.4 Aprepitant Injection Sales and Marketing
7.4.1 Aprepitant Injection Sales Channels
7.4.2 Aprepitant Injection Distributors
7.5 Aprepitant Injection Customers
8 Aprepitant Injection Market Dynamics
8.1 Aprepitant Injection Industry Trends
8.2 Aprepitant Injection Market Drivers
8.3 Aprepitant Injection Market Challenges
8.4 Aprepitant Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Aprepitant Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Aprepitant Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Aprepitant Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Aprepitant Injection Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Aprepitant Injection Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Aprepitant Injection Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Aprepitant Injection Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Aprepitant Injection Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Aprepitant Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Aprepitant Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aprepitant Injection, Product Type & Application
Table 12. Global Key Manufacturers of Aprepitant Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aprepitant Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aprepitant Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aprepitant Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Aprepitant Injection Sales by Region (2018-2024) & (K Units)
Table 18. Global Aprepitant Injection Sales Market Share by Region (2018-2024)
Table 19. Global Aprepitant Injection Sales by Region (2024-2029) & (K Units)
Table 20. Global Aprepitant Injection Sales Market Share by Region (2024-2029)
Table 21. Global Aprepitant Injection Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Aprepitant Injection Revenue Market Share by Region (2018-2024)
Table 23. Global Aprepitant Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Aprepitant Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Aprepitant Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Aprepitant Injection Sales by Country (2018-2024) & (K Units)
Table 27. North America Aprepitant Injection Sales by Country (2024-2029) & (K Units)
Table 28. North America Aprepitant Injection Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Aprepitant Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Aprepitant Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Aprepitant Injection Sales by Country (2018-2024) & (K Units)
Table 32. Europe Aprepitant Injection Sales by Country (2024-2029) & (K Units)
Table 33. Europe Aprepitant Injection Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Aprepitant Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Aprepitant Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Aprepitant Injection Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Aprepitant Injection Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Aprepitant Injection Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Aprepitant Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Aprepitant Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Aprepitant Injection Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Aprepitant Injection Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Aprepitant Injection Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Aprepitant Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Aprepitant Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Aprepitant Injection Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Aprepitant Injection Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Aprepitant Injection Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Aprepitant Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Aprepitant Injection Sales (K Units) by Type (2018-2024)
Table 51. Global Aprepitant Injection Sales (K Units) by Type (2024-2029)
Table 52. Global Aprepitant Injection Sales Market Share by Type (2018-2024)
Table 53. Global Aprepitant Injection Sales Market Share by Type (2024-2029)
Table 54. Global Aprepitant Injection Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Aprepitant Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Aprepitant Injection Revenue Market Share by Type (2018-2024)
Table 57. Global Aprepitant Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Aprepitant Injection Price (US$/Unit) by Type (2018-2024)
Table 59. Global Aprepitant Injection Price (US$/Unit) by Type (2024-2029)
Table 60. Global Aprepitant Injection Sales (K Units) by Application (2018-2024)
Table 61. Global Aprepitant Injection Sales (K Units) by Application (2024-2029)
Table 62. Global Aprepitant Injection Sales Market Share by Application (2018-2024)
Table 63. Global Aprepitant Injection Sales Market Share by Application (2024-2029)
Table 64. Global Aprepitant Injection Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Aprepitant Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Aprepitant Injection Revenue Market Share by Application (2018-2024)
Table 67. Global Aprepitant Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Aprepitant Injection Price (US$/Unit) by Application (2018-2024)
Table 69. Global Aprepitant Injection Price (US$/Unit) by Application (2024-2029)
Table 70. Heron Therapeutics, Inc. Corporation Information
Table 71. Heron Therapeutics, Inc. Description and Business Overview
Table 72. Heron Therapeutics, Inc. Aprepitant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Heron Therapeutics, Inc. Aprepitant Injection Product
Table 74. Heron Therapeutics, Inc. Recent Developments/Updates
Table 75. Qilu Pharmaceutical Corporation Information
Table 76. Qilu Pharmaceutical Description and Business Overview
Table 77. Qilu Pharmaceutical Aprepitant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Qilu Pharmaceutical Aprepitant Injection Product
Table 79. Qilu Pharmaceutical Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Aprepitant Injection Distributors List
Table 83. Aprepitant Injection Customers List
Table 84. Aprepitant Injection Market Trends
Table 85. Aprepitant Injection Market Drivers
Table 86. Aprepitant Injection Market Challenges
Table 87. Aprepitant Injection Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Aprepitant Injection
Figure 2. Global Aprepitant Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Aprepitant Injection Market Share by Type in 2022 & 2029
Figure 4. Injection Product Picture
Figure 5. Injection Lotion Product Picture
Figure 6. Global Aprepitant Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Aprepitant Injection Market Share by Application in 2022 & 2029
Figure 8. Cancer Treatment Center
Figure 9. Hospital
Figure 10. Global Aprepitant Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Aprepitant Injection Market Size (2018-2029) & (US$ Million)
Figure 12. Global Aprepitant Injection Sales (2018-2029) & (K Units)
Figure 13. Global Aprepitant Injection Average Price (US$/Unit) & (2018-2029)
Figure 14. Aprepitant Injection Report Years Considered
Figure 15. Aprepitant Injection Sales Share by Manufacturers in 2022
Figure 16. Global Aprepitant Injection Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Aprepitant Injection Players: Market Share by Revenue in 2022
Figure 18. Aprepitant Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Aprepitant Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Aprepitant Injection Sales Market Share by Country (2018-2029)
Figure 21. North America Aprepitant Injection Revenue Market Share by Country (2018-2029)
Figure 22. United States Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Aprepitant Injection Sales Market Share by Country (2018-2029)
Figure 25. Europe Aprepitant Injection Revenue Market Share by Country (2018-2029)
Figure 26. Germany Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Aprepitant Injection Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Aprepitant Injection Revenue Market Share by Region (2018-2029)
Figure 33. China Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Aprepitant Injection Sales Market Share by Country (2018-2029)
Figure 41. Latin America Aprepitant Injection Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Aprepitant Injection Sales Market Share by Country (2018-2029)
Figure 46. Middle East & Africa Aprepitant Injection Revenue Market Share by Country (2018-2029)
Figure 47. Turkey Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. UAE Aprepitant Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Global Sales Market Share of Aprepitant Injection by Type (2018-2029)
Figure 51. Global Revenue Market Share of Aprepitant Injection by Type (2018-2029)
Figure 52. Global Aprepitant Injection Price (US$/Unit) by Type (2018-2029)
Figure 53. Global Sales Market Share of Aprepitant Injection by Application (2018-2029)
Figure 54. Global Revenue Market Share of Aprepitant Injection by Application (2018-2029)
Figure 55. Global Aprepitant Injection Price (US$/Unit) by Application (2018-2029)
Figure 56. Aprepitant Injection Value Chain
Figure 57. Aprepitant Injection Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed